Priority Date: 10.06.16 (JP 20160116367)

METHOD FOR PREDICTING EFFECT OF PHARMACOTHERAPY ON CANCER

  • Application ID: EP17809918
  • Status: Request for examination was made

Applicant

Research organisation logo small
Research Organisation

Attorney

Employment test 51 - 200 employees
Company dna hoffmann eitle
operating since 1892
Headquarter in Munich and 6 offices
active in Legal Services and IP Portfolio Processing

Specialization

This EP application has the IPC combination A61, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 74 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 10.06.2016 - Priority Date (JP 20160116367)
  • 14.12.2017 - Publication A1 (WO2017212734)
  • 17.04.2019 - Publication A1 (EP3470528)